• rss
  • facebook
  • twitter
  • linkedin

HIV

The PMC reviewed relevant performance measures and makes the following recommendations.

Printable version of the recommendations.
Addendum to printable version of the recommendations.

 ID #Measure NameRecommendation
NQF 0403
Included in Meaningful Use, but not PQRS

HIV/AIDS: Medical Visit
Percentage of patients, regardless of age, with a diagnosis of HIV/AIDS, with at least two medical visits during the measurement year, with a minimum of 90 and 180 days between each visit
Date Reviewed: July 26, 2014

Thumbs Down

More information

NQF 0404
PQRS 159

HIV/AIDS: CD4 Cell Count or Percentage Performed
Percentage of patients aged six months and older with a diagnosis of HIV/AIDS, with at least two CD4 cell counts or percentages performed during the measurement year at least 3 months apart
Date Reviewed: July 26, 2014

Thumbs Up

More information

NQF 0405
PQRS 160

HIV/AIDS: Pneumocystis jiroveci pneumonia (PCP) Prophylaxis
Percentage of patients aged 6 weeks or older with a diagnosis of HIV/AIDS, who were prescribed Pneumocystis jiroveci pneumonia (PCP) prophylaxis
Date Reviewed: July 26, 2014

Thumbs Up

More information

PQRS 161
[No longer NQF-Endorsed]

HIV/AIDS: Adolescent and Adult Patients who are Prescribed Potent Antiretroviral Therapy
Percentage of patients with a diagnosis of HIV/AIDS, with at least two visits during the measurement year, with at least 90 days between each visit: aged 13 years and older who have a history of a CD4 count less than or equal to 500 cells/mm3; aged 13 years and older who have a history of an AIDS-defining illness, regardless of CD4 count; or who are pregnant, regardless of CD4 count or age, who were prescribed potent antiretroviral therapy
Date Reviewed: July 26, 2014

Thumbs Down

More information

PQRS 162
[No longer NQF-Endorsed]

HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretroviral Therapy
Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS, who had at least two medical visits during the measurement year, with at least 90 days between each visit, who are receiving potent antiretroviral therapy, who have a viral load < 200 copies/mL after at least 6 months of potent antiretroviral therapy
Date Reviewed: July 26, 2014

Thumbs Down

More information

NQF 0409
PQRS 205

HIV/AIDS: Sexually Transmitted Diseases Screening for Chlamydia, Gonorrhea, and Syphilis
Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS, who have received chlamydia, gonorrhea, and syphilis screenings at least once since the diagnosis of HIV infection
Date Reviewed: July 26, 2014

Thumbs Down

More information

NQF 0413

HIV/AIDS: Screening for High Risk Sexual Behaviors
Percentage of patients, aged 13 years and older, who were screened for high risk sexual behaviors at least once within 12 months.
Date Reviewed: November 7, 2015

Thumbs Down

More information

NQF 0579

Annual cervical cancer screening or follow-up in high-risk women
This measure identifies women age 12 to 65 diagnosed with cervical dysplasia (CIN 2), cervical carcinoma-in-situ, or HIV/AIDS prior to the measurement year, and who still have a cervix, who had a cervical CA screen during the measurement year.
Date Reviewed: November 7, 2015

Thumbs Up

More information

NQF 2079

HIV medical visit frequency
Percentage of patients, regardless of age, with a diagnosis of HIV who had at least one medical visit in each 6-month period of the 24-month measurement period with a minimum of 60 days between medical visits
A medical visit is any visit in an outpatient/ambulatory care setting with a nurse practitioner, physician, and/or a physician assistant who provides comprehensive HIV care.
Date Reviewed: November 7, 2015

Thumbs Down

More information

NQF 2080

Gap in HIV Medical Visits
Percentage of patients, regardless of age, with a diagnosis of HIV who did not have a medical visit in the last 6 months of the measurement year.
A medical visit is any visit in an outpatient/ambulatory care setting with a nurse practitioner, physician, and/or a physician assistant who provides comprehensive HIV care.
Date Reviewed: November 7, 2015

Thumbs Down

More information

NQF 2082

HIV viral load suppression
Percentage of patients, regardless of age, with a diagnosis of HIV with a HIV viral load less than 200 copies/mL at last HIV viral load test during the measurement year
A medical visit is any visit in an outpatient/ambulatory care setting with a nurse practitioner, physician, and/or a physician assistant who provides comprehensive HIV care.
Date Reviewed: November 7, 2015

Thumbs Up

More information

NQF 2083

Prescription of HIV Antiretroviral Therapy
Percentage of patients, regardless of age, with a diagnosis of HIV prescribed antiretroviral therapy for the treatment of HIV infection during the measurement year.
A medical visit is any visit in an outpatient/ambulatory care setting with a nurse practitioner, physician, and/or a physician assistant who provides comprehensive HIV care.
Date Reviewed: November 7, 2015

Thumbs Up

More information

Not an ACP Member?

Join today and discover the benefits waiting for you.

Not an ACP Member? Join today and discover the benefits waiting for you

ACP offers different categories of membership depending on your career stage and professional status. View options, pricing and benefits.

A New Way to Ace the Boards!

A New Way to Ace the Boards!

Ensure you're board-exam ready with ACP's Board Prep Ace - a multifaceted, self-study program that prepares you to pass the ABIM Certification Exam in internal medicine. Learn more.